PMID: 32674206Jul 17, 2020Paper

Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis

Oncology
Ryan McDonald

Abstract

Disease progression and treatment with hydroxychloroquine and azithromycin ere associated with increased all-cause 30-day mortality in patients with cancer compared with patients either in remission or with no evidence of disease, according to data presented during a 2020 American Society of Clinical Oncology Virtual Scientific Program press briefing.

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

Internal and Emergency Medicine
Alice FaninGruppo di Autoformazione Metodologica (GrAM)
The New England Journal of Medicine
Rahul ChoudharyDeepak Kumar
© 2021 Meta ULC. All rights reserved